AstraZeneca PLC (LON: AZN)
London
· Delayed Price · Currency is GBP · Price in GBX| Market Cap | 187.73B |
| Revenue (ttm) | 37.47B |
| Net Income (ttm) | 4.98B |
| Shares Out | 1.55B |
| EPS (ttm) | 3.20 |
| PE Ratio | 37.84 |
| Forward PE | 16.42 |
| Dividend | 2.28 (1.88%) |
| Ex-Dividend Date | Feb 22, 2024 |
| Volume | 1,605,756 |
| Open | 12,186 |
| Previous Close | 12,166 |
| Day's Range | 12,068 - 12,256 |
| 52-Week Range | 9,461 - 12,488 |
| Beta | 0.16 |
| Analysts | n/a |
| Price Target | 13,025.00 (+7.56%) |
| Earnings Date | Jun 10, 2024 |
About AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus... [Read more]
Financial Performance
In 2023, AstraZeneca's revenue was $45.81 billion, an increase of 3.29% compared to the previous year's $44.35 billion. Earnings were $5.96 billion, an increase of 81.11%.
Financial numbers in USD Financial StatementsNews
TOI health news morning briefing
A new side effect, VITT, linked to AstraZeneca's COVID vaccine, has emerged alongside concerns about Thrombotic Thrombocytopenia Syndrome. Hypertension, influenced by genetic factors, poses risks if i...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
AstraZeneca owes Pfizer $107.5 million in damages, a Delaware federal jury said on Friday after finding that AstraZeneca's blockbuster lung cancer drug Tagrisso violated its Wyeth unit's patent rights...
Evaluating Eli Lilly and Co Against Peers In Pharmaceuticals Industry
In today's rapidly changing and fiercely competitive business landscape, it is vital for investors and industry enthusiasts to carefully evaluate companies. In this article, we will perform a comprehe...
‘Inhumane’: Utah mom slaps drug company with lawsuit after suffering COVID vaccine trial injuries
Brianne Dressen shared with Fox News Digital why she decided to file a lawsuit against AstraZeneca after taking part in the drug company's COVID-19 vaccine trial.
1 in 3 Covaxin recipients hit by adverse events: Study
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual abnor...
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity, Data Shows
Thursday, AstraZeneca Plc (NASDAQ: AZN) released high-level results from the SUPERNOVA Phase 3 COVID-19 pre-exposure prophylaxis (prevention) trial. The study showed AstraZeneca's sipavibart (formerl...
AstraZeneca COVID therapy succeeds in late-stage study for the vulnerable
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood...
AstraZeneca's investigational COVID drug meets primary goals in late-stage study
AstraZeneca said on Thursday its investigational drug, sipavibart, met primary goals in preventing COVID-19 in immunocompromised patients in a late-stage trial.
Genetics Played Role in Rare Blood Clots Linked to COVID-19 Vaccines, Researchers Find
Rare but deadly blood clots tied to J&J and AstraZeneca's vaccines were caused by an autoimmune reaction that some people are predisposed to, researchers found.
DoH inks strategic collaboration with Abu Dhabi Health Data Services and AstraZeneca
To Combat Breast Cancer with New Research Platform
Eli Lilly's and AstraZeneca's Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
STOCKHOLM, SWEDEN / ACCESSWIRE / May 15, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB, a pharmaceutical company that develops candidate drugs for CNS diseases, focusing on Alzheimer...
Vaccine Trial Patient In US Sues AstraZeneca, Claiming She Was Left "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with...
US Woman Sues AstraZeneca Over Vaccine, Says She's "Permanently Disabled"
An American woman who claims she was "permanently disabled" after taking part in the US clinical trial of AstraZeneca's COVID-19 vaccine is suing the drug maker because they failed to provide her with...
Utah mom sues AstraZeneca, claiming she was left ‘permanently disabled’ in COVID vaccine trial
Utah mom Brianne Dressen, 42, said in her lawsuit that she "walked into the clinic fine, and walked out the beginning of a nightmare I wouldn’t wish on my worst enemy."
AstraZeneca, Pfizer to invest combined $900M+ in France for R&D, production
CNBC Changemaker & AstraZeneca CFO celebrates AANHPI Heritage Month
AstraZeneca Group CFO Aradhana Sarin says she's proud of her upbringing and the wide cultural understanding that came with it.
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business ...
AstraZeneca’s Covid vaccine is no more – but its remarkable success must not be forgotten | Robin McKie
Although dogged by controversy, the firm’s coronavirus jab saved the lives of millions and helped avert humanitarian crises in nations unable to access costly alternatives Last week’s announcement tha...
AstraZeneca withdraws vaccine: No need to panic
Covid vaccines helped save lives. Rare adverse reactions to them should be seen from scientific lens, not alarmist ones.
AstraZeneca pulls its Covid-19 vaccine from European market
LONDON—The pharma giant AstraZeneca has requested that the European authorization for its Covid-19 vaccine be pulled, according to the EU medicines regulator.
AstraZeneca pulls its COVID-19 vaccine from European market after history of stumbles
Partial results from its first major trial — which Britain used to authorize the vaccine — were clouded by a manufacturing mistake that researchers didn’t immediately acknowledge.
AstraZeneca stock up despite pulling Covid-19 vaccine from European market
The pharma giant AstraZeneca has requested that the European authorisation for its Covid-19 vaccine be pulled, according to the EU medicines regulator.
Disclosed all rare to very rare side-effects of Covid vaccine 'Covishield' since '21: SII
SII disclosed Covishield's rare side-effects in 2021, AstraZeneca withdrew global vaccine due to surplus, TTS. India halted manufacturing, faced mutant strains. Health experts note TTS involves blood ...
AstraZeneca pulls its COVID-19 vaccine from the European market
LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.